Delivery Order SPE2DR25D1109-SPE2DR26FFG5M
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,507.65 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials, with a completion date of December 8, 2025. This non-set-aside, competitively awarded contract operates under a firm fixed-price arrangement and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency has awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 unit vials, with performance scheduled for completion by November 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Xeomin 100 unit vials. The contract utilizes firm fixed pricing and is scheduled for completion by November 7, 2025. This is an unset-aside, competitively awarded delivery order, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials, with performance to be completed by August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible contractors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xeomin 100 unit vials valued at $6,704.88 with a firm fixed price structure. The order is scheduled for completion by August 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,644.72 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Xeomin 200 unit vials. The contract utilizes firm fixed price terms with an ultimate completion date of June 24, 2025, and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Xeomin 200 Unit Vials. This firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement action and is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.10 to AmerisourceBergen Drug Corp for the supply of Xeomin 100 Unit Vials, with an ultimate completion date of November 26, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader relationship with DLA. The pharmaceutical product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Xeomin 200 Unit Vials with a ceiling value of $2,793.70 and an ultimate completion date of October 2, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Xeomin 200 unit vials, with a ceiling value of $13,409.76 and a firm fixed price structure. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 20, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG5MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,888.30 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 unit vials. This competitively awarded, firm fixed-price delivery order, issued on November 14, 2025, will be fulfilled by the vendor's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of December 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA. This award falls under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains, supporting critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 11/14/25 |